BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1537074)

  • 1. Expression of the mdr1 gene in human colorectal carcinomas: relationship with multidrug resistance inferred from analysis of human colorectal carcinoma cell lines.
    Toffoli G; Viel A; Tumiotto L; Maestro R; Biscontin G; Boiocchi M
    Cancer Chemother Pharmacol; 1992; 29(4):283-9. PubMed ID: 1537074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic-resistant phenotype is a multifactorial phenomenon in human colon carcinoma cell lines.
    Toffoli G; Viel A; Tumiotto L; Biscontin G; Rossi C; Boiocchi M
    Br J Cancer; 1991 Jan; 63(1):51-6. PubMed ID: 1671208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
    Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
    Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.
    Park JG; Lee SK; Hong IG; Kim HS; Lim KH; Choe KJ; Kim WH; Kim YI; Tsuruo T; Gottesman MM
    J Natl Cancer Inst; 1994 May; 86(9):700-5. PubMed ID: 7908989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
    Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines.
    Januchowski R; Wojtowicz K; Andrzejewska M; Zabel M
    Biomed Pharmacother; 2014 Feb; 68(1):111-7. PubMed ID: 24140176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New potent verapamil derivatives that reverse multidrug resistance in human renal carcinoma cells and in transgenic mice expressing the human MDR1 gene.
    Mickisch GH; Merlino GT; Aiken PM; Gottesman MM; Pastan I
    J Urol; 1991 Aug; 146(2):447-53. PubMed ID: 1677434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
    Kim JH; Chung JB; Park IS; Kim BS; Yoo NC; Choi JH; Roh JK; Kim HS; Kwon OH; Lee KS
    Yonsei Med J; 1993 Mar; 34(1):35-44. PubMed ID: 8397460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.
    Long BH; Wang L; Lorico A; Wang RC; Brattain MG; Casazza AM
    Cancer Res; 1991 Oct; 51(19):5275-83. PubMed ID: 1717144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1).
    Yan X; Zhao J; Zhang R
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):395-403. PubMed ID: 28667355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
    Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H
    Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
    Chaudhary PM; Roninson IB
    J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemosensitivity patterns and expression of human multidrug resistance-associated MDR1 gene by human gastric and colorectal carcinoma cell lines.
    Park JG; Kramer BS; Lai SL; Goldstein LJ; Gazdar AF
    J Natl Cancer Inst; 1990 Feb; 82(3):193-8. PubMed ID: 1967320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.
    Tsai CM; Chang KT; Perng RP; Mitsudomi T; Chen MH; Kadoyama C; Gazdar AF
    J Natl Cancer Inst; 1993 Jun; 85(11):897-901. PubMed ID: 8098377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cytarabine-induced MDR1 (P-glycoprotein) gene activation in human tumor cells by fatty acid-polyethylene glycol-fatty acid diesters, novel inhibitors of P-glycoprotein function.
    Komarov PG; Shtil AA; Buckingham LE; Balasubramanian M; Piraner O; Emanuele RM; Roninson IB; Coon JS
    Int J Cancer; 1996 Oct; 68(2):245-50. PubMed ID: 8900436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L; DurĂ¡n GE; Chen KG; Dumontet C; Sikic BI
    J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of multidrug resistance in a primitive neuroectodermal tumor cell line.
    Tishler DM; Raffel C
    J Neurosurg; 1992 Mar; 76(3):502-6. PubMed ID: 1346631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.